Lung Cancer Trial, Not Yet Recruiting NCT07256457 Sponsor: Chinese University of Hong Kong Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07256457
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 or older
  • People who have been diagnosed with early-stage non-small cell lung cancer (stage IA, meaning the tumour is 3 cm or smaller and has not spread to lymph nodes or other parts of the body), confirmed through a tissue or cell sample
  • People who are planned to have surgery or a bronchoscopy-based procedure to treat their lung cancer (such as removal of a lung segment, removal of a lobe, or a robotic or navigation-guided ablation procedure)
  • People who are able to attend follow-up visits after their procedure for up to 2 years
  • People who have given their informed consent to participate in the trial

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cancer has spread to nearby lymph nodes or to other parts of the body
  • People who have another active cancer at the same time that could affect the trial results
  • People whose medical records are missing important information, such as tumour size, type of treatment received, or survival status
  • People whose records appear more than once across different data sources
  • People for whom anaesthesia or sedation (used during surgery or bronchoscopy) is medically not suitable
  • People who are unable or unwilling to complete lung function (breathing) tests
  • Women who are pregnant or breastfeeding (for the part of the study that involves new participants going forward)
  • People who are unable or unwilling to follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +852 3505 2618

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
30 June 2029

Where this trial is recruiting

Hong Kong

Primary endpoints

Develop and validate a composite PF score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov